Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial

Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial

Abstract Background With ~ 50 million individuals suffering from post-COVID condition (PCC), low health related quality of life (HRQoL) is a vast problem. Common symptoms of PCC, that persists 3 months from the onset of COVID-19 are fatigue, shortness of breath and cognitive dysfunction. No effectiv...

Full description

Bibliographic Details
Main Authors: Anders Kjellberg, Adrian Hassler, Emil Boström, Sara El Gharbi, Sarah Al-Ezerjawi, Jan Kowalski, Kenny A. Rodriguez-Wallberg, Judith Bruchfeld, Marcus Ståhlberg, Malin Nygren-Bonnier, Michael Runold, Peter Lindholm
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Infectious Diseases
Subjects:
Long COVID
Post COVID condition
HRQoL
RCT
Clinical trial
Hyperbaric oxygen
Online Access:https://doi.org/10.1186/s12879-023-08002-8

Internet

https://doi.org/10.1186/s12879-023-08002-8

Similar Items